-transparent.png){kind=logo}
Three patients with dystrophia myotonica and echocardiographic signs of subclinical cardiopathy had cardiac side effects during oral treatment with phenytoin sodium or carbamazepine. These side effects were dose related: ventricular tachycardia appeared at a toxic serum phenytoin level in one patient and disappeared as the concentration fell within the therapeutic range, and atrioventricular block grade 1 developed in two patients at low serum carbamazepine levels, its severity increasing with the drug level. Given the risk of dangerous side effects, cardiac status needs to be carefully assessed before administration of phenytoin or carbamazepine in the treatment of dystrophia myotonica.
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
January 1994,
Duodecim; laaketieteellinen aikakauskirja,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
September 1994,
Epilepsy research,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
January 1991,
Neurology,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
January 1988,
Epilepsia,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
August 2015,
Journal of child and adolescent psychopharmacology,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
October 1975,
Ugeskrift for laeger,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
January 1987,
Therapeutic drug monitoring,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
October 1983,
Der Nervenarzt,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
January 1988,
Neurology,
L Durelli, and
R Mutani, and
G P Sechi, and
F Monaco, and
N Glorioso, and
G Gusmaroli
January 2006,
Chronobiology international,
